Assessment of cognitive performance among Mexican children and adolescents afflicted by simple to complex congenital heart diseases. Preliminary study by GONZALEZ GONZALEZ, GABRIEL et al.
Contents lists available at ScienceDirect
Progress in Pediatric Cardiology
journal homepage: www.elsevier.com/locate/ppedcard
Assessment of cognitive performance among Mexican children and
adolescents afflicted by simple to complex congenital heart diseases.
Preliminary study☆
Gabriel González-Gonzáleza, F. Bernardo Pliego-Riveroa, Mario Rodríguez-Camachob,
Gustavo Mendieta Alcántarac, Gloria A. Otero Ojedaa,⁎
a Laboratory of Neurophysiology, Faculty of Medicine, State of Mexico Autonomous University, Toluca, Mexico
b Iztacala Faculty of Higher Education Research Unit, National Autonomous University of Mexico, Mexico City, Mexico
c Department of Pediatric Cardiology, Hospital for the Child, IMIEM, Toluca, Mexico







A B S T R A C T
Among patients afflicted by congenital heart diseases (CHD) diverse, and complex neurological alterations are
commonly observed. These have neither been completely identified nor understood. With the aim of identifying
specific neurocognitive alterations among children and adolescents afflicted by CHD we investigated the possible
presence of cognitive disorders related to the presence of cardiovascular disease with the aid of a sample of 20
patients (12 teenagers and 8 school-age children). Taken altogether, 9 of them were afflicted by simple and 11 by
complex pathologies (respectively, CHDs/c). The Neuropsychological Test for Memory and Attention (Neuropsi),
standardized for Mexico by Ostrosky et al. (2004), was individually applied to all participants. The information
of cognitive performance was obtained in relation to the categories attention and memory, and the same areas
allowed us to assess global performance. CHDc subjects performed significantly poorer compared to CHDs in i)
attention and executive function, ii) memory and iii) attention and memory. Likewise, among CHDc subjects a
significantly higher proportion of cases were diagnosed as abnormal in the same variables. Also a significant and
negative correlation was determined between CHD severity and neuropsychological scoring. Children and
adolescents afflicted by CHD are at high risk of developing cognitive function alterations including aspects of
memory, attention and executive functions, alterations which are likely to be worst among those cases carrying
CHDc conditions.
1. Introduction
The incidence of moderate to severe congenital heart disease (CHD)
has been estimated at approximately 6–8 per 1000 children born alive,
constituting in itself the second most frequent disease in infancy [1]. In
México, Mendieta-Alcántara et al. [2] inform of an incidence of 7.4 per
1,000 children born alive. In the last decades, owing to progress in
intervention strategies and surgical treatments the long-term survival
among neonates suffering from CHD has substantially increased.
Nowadays, due to the fact that the survival expectancy is high among a
high percentage of cases, the condition is now considered as a life-long
or chronic disease [3]. In parallel to this, the interest has now im-
portantly progressed towards the identification of possible CHD-corre-
lated afflictions. This is, to functional co-morbidities evolving from
neonatal stages to adolescence, and adulthood. Of specific interest are
the possible alterations which might appear along brain development
due to altered blood perfusion. Reduced tissue oxygenation throughout
development may lead to considerable insufficiencies in terms of cog-
nitive performance.
The biological circumstances, either biochemical or physiological,
underlying the neurological injuries in CHD patients appear to be many,
varied and not entirely clear. These frequently include hypoxia-
ischemia events triggered by hypoperfusion, and this either due to the
pathology itself or resulting from cardiac surgery. A multiplicity of
other factors comprising genetic, prenatal, as well as pre- and post-
operative influences may contribute to the alterations observed among
these patients [4,5].
Some forms of CHDc lead to atypical brain development features,
and these are observed as early as 25–30weeks of intrauterine life [6].
Also, high ratios of microcephaly, and hypotonia, and other alterations
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have been determined by neuroimaging [7]. Other specific lesions in-
clude periventricular leukomalacia, present in up to 59% of cases be-
fore surgery [8].
Lags in neurodevelopment constitute the most frequent co-mor-
bidity conditions among school-age children carrying CHD alterations
[9–11]. In general, IQ is well preserved as it has been determined
among these children. Nevertheless, a significant proportion of cases
show alterations in motor skills, and in the cognitive traits of attention,
memory, and language. Low academic achievement and deficient social
development are also typical manifestations [4,10,12–14].
Commonly, the studies carried among CHD children have centered
focused their attention on early infancy or early school ages. Recently,
Cassidy et al. [15] studied executive function performance among
school-age children and adolescents (10–19 years old) exhibiting cya-
notic CHD. They reached the conclusion that the condition constitutes
in itself an important risk factor for the optimal development and ac-
quisition of executive functions.
Taken altogether, children and teenagers CHD patients, are osten-
sibly at high risk of presenting diverse neurocognitive alterations.
Among them minor skills are often intact although in parallel to the
increased severity of the disease the patients progressively show in-
creased difficulties in integrating and coordinating those skills so as to
achieve higher order goals [16]. According to Bellinger et al. [16–18],
among the most noticeable deficits observed are those related to non-
verbal skills, together with alterations in social cognition, and executive
performance. The severity of the condition, particularly amid complex
cardiopathological cases, poses serious threats to brain development
and the acquisition of optimal cognitive abilities.
Considering that the studies related to the outcome and develop-
ment of CHD-associated afflictions among these patients are still lim-
ited, particularly in Mexico where the comorbidity aspects of CHD are
insufficiently acknowledged, the present work was carried out with the
aim of identifying some of the main cognitive alterations among
Mexican children and adolescents afflicted by CHD (simple and com-
plex) through the application of the neuropsychological test Neuropsi.
2. Materials and Methods
2.1. Ethical Considerations
The present research protocol was approved in advance by the
Bioethics Committee of the School of Medicine, State of Mexico
Autonomous University, in compliance with the Declaration of Helsinki
[19]. In every instance, both parents and participating children were
informed in advance in relation to the aims and procedures of this study
as well as of possible risks and benefits. At the same time, it was clearly
explained that all information was going to be kept confidential and the
results delivered free of charge to the parents of participating minors.
All considerations were included both in the oral explanation as in the
informed written consent. After approval, this last one was signed by
parents and participating children and teenagers.
2.2. Sample
This consisted of 20 patients (9 females and 11 males) of ages be-
tween 7 and 16 years, 12 teenagers and 8 under 13 years old. Of the
whole sample 9 cases were afflicted by uncomplicated CHD conditions,
this is, free of hemodynamic compromise and hereby named simple
(CHDs) and 11 by complex (CHDc) pathologies involving either re-
duced blood flow, reduced blood oxygenation or both. All cases studied
were patients gathered from the Child's Hospital, belonging to the
Institute for the Mother and Children from the State of Mexico (IMIEM),
Toluca City, Mexico. All cases were diagnosed and assessed by a med-
ical doctor specializing in pediatric cardiology and of the total sample,
10 cases had not undergone surgical treatment at the moment of as-
sessment. These data are summarized in Table 1.
2.2.1. Inclusion Criteria
Children and teenagers of ages between 7 and 16 years afflicted by
simple or complex CHD.
2.2.2. Exclusion Criteria
Personal or family background of central nervous system (CNS)-
related alterations including a background of CNS perinatal risk or
damage; genetic conditions which might involve CNS risk or damage;
any physical complaint not allowing them to take the tests; develop-
ment or acquisition of new or correlated pathological alterations along
the course of the study.
2.3. Procedures
Neuropsi (Neuropsychological Test for Memory and Attention) had
been previously standardized for Mexico by Ostrosky et al. [20] was
applied individually to all participants. The instrument includes a base
of normative data for people between the ages of 6–85 years. Neuropsi
was designed to assess in a detailed manner and independently of each
other attention and memory processes as well as to complete a global
estimate among psychiatric, geriatric, neurologic and other patients
presenting diverse medical conditions. Specifically, in this study, the
different areas examined covered various attention subcategories in-
cluding orientation, selective attention, sustained attention and atten-
tional control. Also, diverse subtypes of memory were evaluated.
Among them working, verbal and visuospatial short and long-term
memories. The test provided qualitative and quantitative estimates
from both raw and normalized data. Separately, Neuropsi provided
information of performance in the cognitive categories of attention and
memory, and in this area of global performance too. The subdivision of
the test in categories and subcategories allows the clinician or research
worker to precisely identify the presence of attention or memory defi-
cits in the patient under examination (see Table 2).
2.4. Statistical Analysis
To investigate the existence of differences between groups (CHDs vs.
CHDc) and due to the size of the sample, a non-parametric and multi-
variate permutation test was applied [21,22]. This method does not
require a normal distribution of data due to the construction of its own
empiric distribution. Thus, the global test was calculated applying the
permutation distribution of the Student's t-test maximum (tmax). After
applying the permutation technique, the estimated distribution of tmax
served to set the levels of significance, a procedure which at the same
time controls and avoids increasing type I error. Using the Student's t-
Table 1
Types of congenital heart diseases diagnosed in the studied sample.
Cardiopathy n Type Previous surgery
Coarctation of aorta 1 CHDc Yes
Ventricular septal defect 1 CHDc Yes
Atrial septal defect 3 CHDs Yes
Patent ductus arteriosus 3 CHDs No
Patent oval foramen 3 CHDs No
Severe pulmonary stenosis 1 CHDc Yes
Ebstein anomaly 1 CHDc No
Tetralogy of Fallot 1 CHDc Yes
Pulmonary atresia 1 CHDc Yes
Common arterial trunk 1 CHDc No
Atrial septal defect and Ebstein anomaly 1 CHDc No
Tricuspid atresia 1 CHDc No
Transposition of the great arteries and single
ventricle
1 CHDc Yes
Coarctation of aorta+ secondary systemic arterial
hypertension
1 CHDc Yes
CHDs: simple congenital heart diseases; CHDc: complex congenital heart diseases.
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test, multiple comparisons were carried out by computing all paired-
wise comparisons. Thus, the global hypothesis stating CHDs is different
from CHDc was applied to evaluate the differences between groups
simultaneously. Therefore this test is particularly useful because it takes
into account each item, and from this it determines if there is a global
and statistically significant difference between groups. Marginal hy-
potheses were used to test differences per variable. The test was applied
to assess the mean differences among the data obtained from the next
globally tested neuropsychological pairs of variables: a) groups CHDs
and CHDc; b) age groups, i.e., children and adolescents; c) subjects with
or without previous surgery.
Nevertheless, in order to be stricter we proceeded as follows. This
comparative study although it shows there are significant differences
between groups both globally and in specific variables, it doesn't tell us
whether there are individuals showing abnormal cognitive scoring
within any of both groups (CHD simple and complex), neither it informs
us about the percentage of abnormal cases within each group.
Considering that Neuropsi has been standardized in Mexico, standar-
dization allowed us then to determine normal and abnormal perfor-
mance per group, and the percentage of normal/abnormal cases within
each group (CHDs/c). The statistical significance of the differences
between these percentages was determined by employing the software
Statistica 8.
On the other hand the statistical software SPSS (version 21) was
used to assess any possible correlation between the severity of the heart




By applying the multivariate permutation test [22] a highly sig-
nificant global probability (p < 0.001) was found, indicating the ex-
istence of considerable and significant differences between the groups
CHDs and CHDc. This global result may only be obtained after de-
termining statistical differences of individual items between groups. As
can be appreciated here next, there are items which show highly sig-
nificant differences between CHDs and CHDc patients. These include
attention and executive function (p= 0.01); memory (p=0.001), and;
attention and memory (p=0.001). These global variables themselves
summarize the results obtained from statistically different subitems (see
below), and all of these obtained in a similar way to the IQ Waiss In-
telligence Test design.
The statistically different subitems between groups were orientation
(p= 0.02); attention and concentration (p=0.001); working memory
(p= 0.001); memory codification (p=0.001); spontaneous verbal
memory (p=0.001), and; executive functions (p=0.001). No sig-
nificant differences were found, however, when comparisons were
made taking into account age groups (children vs. adolescents), and
neither between cases who had or not undergone cardiovascular sur-
gery before this study.
3.2. Test of Proportions Differences
After determining performance within each global item tested, the
final score was allocated a “normal” or “abnormal” category if, re-
spectively, the result attained was within or under the rating corre-
sponding to the Neuropsi test given standards of “normality.” A hy-
pothesis test of proportions differences was then applied. Group CHDc
showed a significantly higher proportion of cases diagnosed as ab-
normal in aspects of attention (p=0.003), memory (p=0.003), and
attention and executive function (p=0.03) compared to CHDs.
3.3. Spearmen Correlation Test
Finally, the Spearman test of correlation was applied to compare the
severity of the individual cardiopathology to the results determined for
each psychometric variable (Table 3). Neuropsi showed a highly sig-
nificant and negative correlation concerning the severity of the disease
(CHDc) in all items tested.
4. Discussion
4.1. CHDc vs CHDs
In the present study, 20 Mexican children and adolescents carrying
CHD, of whom 45% of them were diagnosed as simple and 55% as
complex, were assessed concerning their neurodevelopment through
the application of the psychometric battery test Neuropsi. Of the two
groups presenting CHD, they either did not show hemodynamic com-
promise (CHDs) or this was present (CHDc), and between them pre-
sented significant differences in traits of attention and executive func-
tions (p=0.006), memory (p=0.001), and in memory and attention
(p= 0.0001). These results, obtained among a sample of Mexican pa-











MORY Working memory Digits retention (regression)
Regression cubes
Codification Average volume memory curve
Average volume associated pairs
Average logic history memory
Semi-complex figure
Faces
Emotion Full spontaneous verbal memory
Full key verbal memory
Full verbal memory recognition
Full associated pairs
Average logic history memory
Semi-complex figure
Full face recognition
EXECUTIVE FUNCTIONS Categories formation
Full semantic verbal fluency
Full phonologic verbal fluency

















ATEF: attention and executive functions; MEM: memory; ATMEM: attention and memory;
CHD: congenital heart diseases; ATT-CONC: attention and concentration; WM: working
memory; EVOC-MEM: evocative memory; EXEC-FUNC: executive functions.
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determined the cognitive profile of school age children afflicted by CHD
after surgery by applying an abbreviated intelligence scale and asses-
sing their neuropsychological development. Within group CHD the
authors found significantly lower scores in the full scale of estimated
IQ. The neuropsychological evaluation also revealed lower scores in the
cognitive domains of sensorimotor performance, language, attention,
executive functions and memory, and increased impulsiveness com-
pared to a group of healthy peers.
Executive functions constitute a set of superior neurocognitive
abilities related to the coordination and organization of actions towards
specific goals, allowing the individual to adapt to new and complex
situations. These cognitive skills are critical for the accomplishment of
social and academic tasks. A deterioration of executive functions in
cases of CHDc was one of the findings of our study. It has been and is
still of particular interest to other authors because it appears to be a
specific area of cognitive weakness among children suffering from
congenital heart disease [5,15,23,24]. Although deficiencies in diverse
aspects of neurodevelopment are widespread among CHD children,
these may not be apparent until school age is reached. In this sense,
Calderon et al. [5] studied longitudinally (3 years) executive functions
(EF) among a group of 45 children of ages of 5–7 years afflicted by
transposition of the great arteries. Compared to a control group of
healthy children the results showed that most EF impairments had an
early onset at a preschool age. The alterations persisted and continued
to have an impact, from moderate to substantial, later in life. Coin-
ciding with Calderon et al. [5,23], in our study both CHDc children and
adolescents showed lower scores in items concerning to executive
function.
Alterations of EF among CHD children and adolescents have also
been found by other authors. Cassidy et al. [15] studied 463 CHD
children and teenagers and compared them to a control group of
healthy individuals (111 participants). The degree of EF deterioration,
according to the application of different tests, was higher among CHD
patients compared to the control group. According to the conclusions of
these authors, CHD represents a severe threat to EF development in
direct correlation to the severity of the disease. In the present study,
and in agreement with observations by other authors, among CHDc
patients, we found deficits in attention, memory, and executive func-
tions. In this sense, Shillingford et al. [25] investigated the presence of
attention disturbances among a group of 5–10-years old children af-
flicted by CHDc. According to the Attention Deficit and Hyperactivity
Disorder-IV Rating Scale, 30% of CHD children observed high-risk
scores of inattention and 29% of them high-risk scores of hyperactivity.
Several studies have applied tests of attention to CHD children, evi-
dencing among them deficiencies in this domain.
Bellinger et al. [9] assessed the ability of sustained attention ap-
plying a continuous performance test to a group of 8 years old children
with transposition of the large arteries, and among them found more
omissions and mistakes, as well as multiple responses, and longer than
average reaction times. Concurring with the above mentioned authors,
we found a worsened performance in memory tests within group CHDc,
evidencing a deterioration of various forms of memory. It is important
to note that in all the hereby cited studies, the authors compare neu-
ropsychological performance between cases bearing congenital heart
disease to healthy controls. In the current study, all comparisons were
made between CHD cases, simple vs. complex. To our knowledge, this is
the first study among young CHD patients doing this type of assessment.
Postoperatively Miatton et al. [12] identified significantly lower
scores in a CHD group compared to their healthy counterparts in the
cognitive domains of sensorimotor functioning, language, attention and
executive function, and memory. CHD children also showed increased
impulsive behavior in the applied tests, all of which also coincides with
our results. Recently Sanz et al. [24] determined the profile and pre-
valence of executive dysfunction in a sample of school-age children
with CHD, concluding that school-age children with CHD have a higher
prevalence of this trait, and in particular, difficulties with working
memory and flexibility compared to a control group of healthy peers.
4.2. Normal vs. Abnormal Neurocognition Within Each Group
In this work, another piece of evidence supporting the higher risk of
developing cognitive dysfunction among CHDc cases includes the pre-
sence of a higher proportion of people diagnosed as cognitively “ab-
normal”. It is important to note that categorizing a particular test result
as “cognitive abnormality” is not an exclusive feature of the most
complex CHD cases, as it was also observed among CHDs individuals.
One of the most important conclusions of our work is related to the
need of early assessing neuropsychologically and neurodevelopmen-
tally all CHD cases (simple, and severe) in order to take appropriate
medical and neuropsychological action.
4.3. CHD and Its Severity
Neither age nor surgical treatment appeared to influence the cog-
nitive traits studied here. Specifically designed studies would have to be
devoted to any of both aspects. In our study the main and strongest
influence for the presence of cognitive disturbances, or neurodevelop-
ment lags is the cardiopathology itself and the extent of its severity.
Nevertheless, this is a preliminary result which for further and more
comprehensive conclusions would require a larger sample. The present
study by far has been constrained by the number of cases dealt with by
the local Hospital for the Child who are routinely captured.
4.4. Spearman Correlation Test
We found a very high and significant negative correlation between
the severity of CHD and neurocognitive performance. Other authors
have only found correlation between CHD severity and performance in
executive function. Calderon et al. [23] point out that the greater the
severity of CHD, the worse is the determined performance in those tasks
exploring executive functions. In parallel, CHD children and adoles-
cents face increased risks of speech/language, attention, memory, and
visual-spatial skills deficits [26,27]. In our work we consider important
to establish a relationship between the dependent variables (Neuropsi
items) and the independent one (severity of heart disease) among cases
of CHD, simple and complex. We have corroborated among children
and adolescents with CHD (simple and complex) that as a group they
are likely to show greater neuropsychological deterioration in direct
relationship to the severity of heart disease.
In summary, children, and adolescents afflicted by congenital heart
disease show alterations in aspects of cognitive functions including
memory, attention and executive functions, alterations which were
more noticeable among those cases carrying the complex conditions.
This is, those patients presenting severe hemodynamic compromise,
and this regardless of age or medical treatment, including surgery.
Although subject to further investigation, those alterations in cognition
and behavior most like are the result of an atypical brain development
present since fetal stages up to late infancy due to cardiological and
systemic complications.
Current medical and technical progress has increased the survival
rate of children suffering from congenital heart disease thereby al-
lowing a higher number of patients to surpass infancy and reach
adulthood. Thanks to these advances, a higher probability of normal
integration into family and social life exists. Nevertheless, in spite of
attaining an overall body condition of physical bodily health, there may
be present underlying CNS alterations which have to be looked after.
Taking into account the results of this study and observations by other
authors, the neurocognitive complications resulting from CHD are
likely to carry wider and long lasting adverse effects.
Finally, we consider essential to note that in Mexico few studies
investigate the presence of neuropsychological alterations in children
and adolescents with CHD. This study not only presents patients from
G. González-González et al. Progress in Pediatric Cardiology 48 (2018) 93–97
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Mexico but also and importantly compares neurocognitive performance
among CHD patients suffering from a simple to a severe heart pa-
thology, being both novel aspects and contributing thus to the growing
literature on this topic.
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